Omar Novelo is a visionary health-innovation entrepreneur and the founder of Neorgana, a leading company in cellular and longevity therapies in Latin America. With more than a decade of experience, he has forged strategic alliances with world-renowned scientists and centers to bring technologies such as DEZAWA MUSECells®, exosomes, and epigenetic peptides into clinical practice. Under his leadership, Neorgana has become a recognized leader in elite regenerative medicine, prioritizing safety, innovation, and outcomes, and positioning itself at the forefront of the global longevity movement.
Dr. José Omar Novelo is a leading authority in regenerative medicine, recognized for his expertise in integrating cutting-edge cellular and molecular therapies. He combines DEZAWA MUSE Cells®, intravenous DEZAWA MUSE Exosomes®, to deliver highly personalized, measurable treatments that address the root causes of aging and degeneration. His clinical scope ranges from longevity and preventive medicine to complex neurodegenerative and autoimmune conditions. As National Medical Director of Neorgana, Dr. Novelo upholds the highest standards of precision and patient-centered care, positioning Neorgana as a premier destination for high-end regenerative healthcare—trusted by discerning, health-conscious individuals and pioneers of next-generation medicine.
Mohanad Ghabra leads Neorgana’s presence across the Middle East and North Africa (MENA) region as Managing Partner. With deep cultural insight and a refined understanding of the region’s unique dynamics, Mohanad ensures that Neorgana’s operations in MENA reflect the highest standards of service, discretion, and personalization.
With years of experience serving high-profile clients across both public and private sectors, he brings a rare ability to anticipate expectations, deliver with precision, and build lasting trust. His leadership enables us to offer a true concierge experience—tailored not only to the needs but also to the values and traditions of the region’s most discerning clientele.
As we launch our state-of-the-art Longevity & Biohacking Clinic in the Middle East—offering the world’s most advanced biotechnology for wellness optimization and the treatment of complex medical conditions—Mohanad plays a key role in bridging global innovation with local sophistication.
Dr. Sara Gabriela González Sánchez is a medical doctor graduated from Universidad La Salle, with specialized training in Anesthesiology at Hospital Ángeles Metropolitano. Her clinical focus has evolved toward advanced pain management and palliative care, having completed a high-specialty program at the National Institute of Medical Sciences and Nutrition Salvador Zubirán in affiliation with the National Autonomous University of Mexico (UNAM).
She has extensive training in regional anesthesia (ARMTY) and advanced interventional pain procedures through diplomas from AMETD and Universidad Panamericana. Currently, she serves as an adjunct professor in both basic and advanced interventional diplomas at AMETD and holds the position of Delegate on the Board of Directors of the Mexican Association for the Study and Treatment of Pain (AMETD).
Dr. González Sánchez practices at renowned institutions such as Hospital Ángeles Pedregal and Hospital Punta Médica, where she applies a comprehensive and cutting-edge interventional approach to the treatment of acute and chronic pain, in alignment with the highest standards of regenerative and personalized medicine.
